January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

Developers celebrate gains for advances with radiopharmaceuticals while regulators and isotope suppliers work to keep up.

Real-time index price for TSX Oil and Gas EW Index (TXOE), along with buy or sell indicators, analysis, charts, historical ...

Sanofi-Aventis US LLC filed a lawsuit against the Department of Health and Human Services (HHS) and the Health Resources and ...

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.

The S&P 500 index trades at a forward price/earnings ratio of 21.9. The U.S. large-cap benchmark stock index is weighted by market capitalization. The index's current forward P/E valuation is 18% ...

Launched on 12/16/1998, the Health Care Select Sector SPDR ETF (XLV) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Broad segment of the equity ...

If you're interested in broad exposure to the Healthcare - Broad segment of the equity market, look no further than the iShares U.S. Healthcare ETF (IYH), a passively managed exchange traded fund ...

Healthcare stocks have jumped, but the easy money has already been made. Now, these companies have to offer strong profit ...

Real-time index price for TSX 60 Index (TXSX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Most next-generation treatments are aiming to be second or third line treatments for when Johnson & Johnson’s ... for ways to gain an advantage over Eli Lilly’s rival IL-17A inhibitor, Taltz ...

R.M.B. has done clinical trials and consulted or served on a scientific advisory board for Abbott Diabetes Care, Becton Dickinson, Bayer, Dexcom, Eli Lilly, Johnson & Johnson, Medtronic ...